Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation

Neuroscience

Volumn 74, Issue 2, 1996, Pages 403-414

  Jung, M ^a   Michaud, J C ^a   Steinberg, R ^a   Barnouin, M C ^a   Hayar, A ^b   Mons, G ^a   Souilhac, J ^a   Emonds Alt, X ^a   Soubrie P ^a   Le Fur, G ^a  

^a SANOFI   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

gerbil; guinea pig; locus coeruleus; senktide; SR 142801; adrenergic receptor

Indexed keywords

CLONIDINE; NEUROKININ 3 RECEPTOR; NEUROKININ 3 RECEPTOR AGONIST; NEUROKININ B [7 METHYLPHENYLALANINE]; NORADRENALIN; OSANETANT; PRAZOSIN; SENKTIDE; URETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GERBIL; GUINEA PIG; LOCOMOTION; LOCUS CERULEUS; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; REARING;

EID: 0030593435     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00150-9     Document Type: Article

References (49)

1. 2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem. biophys. Res. Commun. 184:1992;1418-1424.
2. Aghajanian G.K., Rasmussen K. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse. 3:1989;331-338.
3. Aston-Jones G., Bloom F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1:1981;876-886.
4. 1 receptor activation in gerbils. Eur. J. Pharmac. 253:1994;245-252.
5. Buell G., Schulz M.F., Arkinstall S.J., Maury K., Missotten M., Adami N., Talabot F., Kawashima E. Molecular characterisation, expression and localisation of human neurokinin-3 receptor. Fedn Eur. biochem. Socs Lett. 299:1992;90-95.
6. Butler P.D., Weiss J.M., Stout J.C., Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 10:1990;176-183.
7. Cheeseman H.J., Pinnock R.D., Henderson G. Substance P excitation of rat locus coeruleus neurones. Eur. J. Pharmac. 94:1983;93-99.
8. 3H]senktide. Brain. Res. 506:1990;175-179.
9. Dam T.V., Quirion R. Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain. Peptides. 7:1986;855-864.
10. 3 receptor. Life Sci. 56:1995;27-32.
11. 1 receptor antagonist. Eur. J. Pharmac. 250:1993;403-413.
12. 2) receptor. Life Sci. 50:1992;101-106.
13. Everitt B.J., Robbins T.W., Gaskin M., Fray P.J. The effects of lesions to ascending noradrenergic neurons on discrimination, learning and performance in the rat. Neuroscience. 10:1983;397-410.
14. Finlay J.M., Zigmond M.J., Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 64:1995;619-628.
15. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63:1983;844-914.
16. Guard S., Watson S.P. Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem. Int. 18:1991;149-165.
17. Harris G.C., Fitzgerald R.D. Locus coeruleus involvement in the learning of classically conditioned bradycardia. J. Neurosci. 11:1991;2314-2320.
18. Henderson G., Pepper C.M., Shefner S.A. Electrophysiological properties of neurones contained in the locus coeruleus and mesencephalic nucleus of the trigeminal nerve in vitro. Expl Brain. Res. 45:1982;29-37.
19. Huang R.R.C., Cheung A.H., Mazina K.E., Strader C.D., Fong T.M. cDNA sequence and heterologous expression of the human neurokinin-3 receptor. Biochem. biophys. Res. Commun. 184:1992;966-972.
20. Humpel C., Saria A. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonist biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A messenger RNA in the rat. Neurosci. Lett. 157:1993;223-226.
21. 1 receptors. Neuropharmacology. 33:1994;167-179.
22. 3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro. Br. J. Pharmac. 105:1992;3-5.
23. Liminga U., Johansson P.E., Gunne L. Intranigral tachykinin NK3 receptor agonist elicits oral movements in rats. Pharmac. Biochem. Behav. 38:1991;617-620.
24. Maggi C.A., Patacchini R., Rovero P., Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J. auton. Pharmac. 13:1993;23-93.
25. Mason G.S., Elliott P.J. Behavioural consequences following infusion of selective neurokinin agonists into the median raphe nucleus of the rat. Neuropharmacology. 31:1992;757-760.
26. 1) receptor antagonist. Science. 251:1991;437-439.
27. McLean S., Ganong A., Seymour P.A., Snider R.M., Desai M.C., Rosen T., Bryce D.K., Longo K.P., Reynolds L.S., Robinson G., Schmidt A.W., Siok C., Heym J. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J. Pharmac. exp. Ther. 267:1993;472-479.
28. Nutt D.J., Glue P. Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmac. Ther. 4:1989;309-334.
29. Paris J.M., Lorens S.A. A dose-response analysis of intra-raphe tachykinin-induced hyperactivity. J. Pharmac. exp. Ther. 251:1989;388-393.
30. Paris J.M., Mitsushio H., Lorens S.A. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions. Brain Res. 476:1989;183-188.
31. Poncelet M., Gueudet C., Emonds-Alt X., Brelière J.C., Le Fur G., Soubrié P. Turning behaviour induced in mice by a neurokinin A receptor agonist: stereoselective blockade by SR 48968, a non-peptide receptor antagonist. Neurosci. Lett. 149:1993;40-42.
32. Rapisarda C., Bacchelli B. The brain of the guinea pig in stereotaxic coordinates. Arch. Sci. Biol. 61:1977;1-37.
33. Rasmussen K., Morilak D.A., Barry L.J. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res. 371:1986;324-334.
34. Ratkovsky D.A., Reedy T.J. Choosing near-linear parameters in the four-parameters logistic model for radioligands and related assays. Biometrics. 42:1986;575-582.
35. Redmond J. D. E. (1979) New and old evidence for the involvement of a brain norepinephrine system in anxiety. In Phenomenology and Treatment of Anxiety (ed. Fann W. E.), pp. 153-203. New York, Spectrum.
36. Regoli D., Boudon A., Fauchére J.C. Receptors and antagonists for substance P and related peptides. Pharmac. Rev. 46:1994;551-599.
37. 2 receptor antagonist. J. Pharmac. exp. Ther. 262:1992;759-768.
38. 1 receptor antagonists. Eur. J. Pharmac. 265:1994;179-183.
39. 3 ligands) in the rat brain. Peptides. 9:1988;227-241.
40. Seabrook G.R., Bowery B.J., Hill R.G. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Eur. J. Pharmac. 273:1995;113-119.
41. Seabrook G.R., Main M.J., Hill R.G. Pharmacology of neurokinin receptors on neurones within brain slices of the guinea-pig locus coeruleus. Br. J. Pharmac. 107:1992;228P.
42. Simson P.E., Weiss J.M. Alpha-2 receptor blockade increases responsiveness of locus coeruleus neurons to excitatory stimulation. J. Neurosci. 7:1987;1732-1740.
43. 3H]serotonin release from rat cerebral cortex by neuromedin K and substance P acting at distinct receptor sites. Brain Res. 401:1987;377-380.
44. Steinberg R., Rodier D., Souilhac J., Bougault I., Emonds-Alt X., Soubrié P., Le Fur G. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J. Neurochem. 65:1995;2543-2548.
45. 3H]senktide. Brain Res. 534:1990;1-7.
46. Tanaka T., Yokoo H., Mizoguchi K., Yoshida M., Tsuda A., Tanaka M. Noradrenaline release in the rat amygdala is increased by stress: studies with intracerebral microdialysis. Brain Res. 544:1991;174-176.
47. Tremblay L., Kemel M.L., Desban M., Gauchy C., Glowinski J. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc. natn. Acad. Sci. U.S.A. 89:1992;11214-11218.
48. Whitty C.J., Walker P.D., Goebel D.J., Poosch M.S., Bannon M.J. Quantitation, cellular localization and regulation of neurokinin receptor gene expression whithin the rat substantia nigra. Neuroscience. 64:1995;419-425.
49. Yip J. and Chahl L. A. (1995) Effect of the novel NK-3 receptor antagonist, SR 142801, on the distribution of c-Fos in guinea-pig brain following intracerebroventricular injection of substance P and senktide. Presentation to Tachykinins '95, Florence, Italy.